norris biomedical services limited
norris biomedical services limited Company Information
Company Number
08358664
Website
www.norrisbiomedical.comRegistered Address
20 finch mill avenue, appley bridge, wigan, WN6 9DF
Industry
Management consultancy activities (other than financial management)
Telephone
-
Next Accounts Due
February 2025
Group Structure
View All
Directors
Michael Norris11 Years
Shareholders
north west fund for biomedical lp 84%
yvonne norris 8%
View Allnorris biomedical services limited Estimated Valuation
Pomanda estimates the enterprise value of NORRIS BIOMEDICAL SERVICES LIMITED at £43.9k based on a Turnover of £102k and 0.43x industry multiple (adjusted for size and gross margin).
norris biomedical services limited Estimated Valuation
Pomanda estimates the enterprise value of NORRIS BIOMEDICAL SERVICES LIMITED at £0 based on an EBITDA of £0 and a 3.26x industry multiple (adjusted for size and gross margin).
norris biomedical services limited Estimated Valuation
Pomanda estimates the enterprise value of NORRIS BIOMEDICAL SERVICES LIMITED at £133.3k based on Net Assets of £54.2k and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Norris Biomedical Services Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Norris Biomedical Services Limited Overview
Norris Biomedical Services Limited is a live company located in wigan, WN6 9DF with a Companies House number of 08358664. It operates in the management consultancy activities other than financial management sector, SIC Code 70229. Founded in January 2013, it's largest shareholder is north west fund for biomedical lp with a 84% stake. Norris Biomedical Services Limited is a established, micro sized company, Pomanda has estimated its turnover at £102k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Norris Biomedical Services Limited Health Check
Pomanda's financial health check has awarded Norris Biomedical Services Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 5 areas for improvement. Company Health Check FAQs
0 Strong
2 Regular
5 Weak
Size
annual sales of £102k, make it smaller than the average company (£278.8k)
- Norris Biomedical Services Limited
£278.8k - Industry AVG
Growth
3 year (CAGR) sales growth of -15%, show it is growing at a slower rate (6.1%)
- Norris Biomedical Services Limited
6.1% - Industry AVG
Production
with a gross margin of 25.4%, this company has a higher cost of product (53.4%)
- Norris Biomedical Services Limited
53.4% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Norris Biomedical Services Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (3)
1 - Norris Biomedical Services Limited
3 - Industry AVG
Pay Structure
on an average salary of £41.2k, the company has an equivalent pay structure (£41.2k)
- Norris Biomedical Services Limited
£41.2k - Industry AVG
Efficiency
resulting in sales per employee of £102k, this is equally as efficient (£109.7k)
- Norris Biomedical Services Limited
£109.7k - Industry AVG
Debtor Days
it gets paid by customers after 194 days, this is later than average (71 days)
- Norris Biomedical Services Limited
71 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Norris Biomedical Services Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Norris Biomedical Services Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Norris Biomedical Services Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Norris Biomedical Services Limited
- - Industry AVG
norris biomedical services limited Credit Report and Business Information
Norris Biomedical Services Limited Competitor Analysis
Perform a competitor analysis for norris biomedical services limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
norris biomedical services limited Ownership
NORRIS BIOMEDICAL SERVICES LIMITED group structure
Norris Biomedical Services Limited has no subsidiary companies.
Ultimate parent company
NORRIS BIOMEDICAL SERVICES LIMITED
08358664
norris biomedical services limited directors
Norris Biomedical Services Limited currently has 1 director, Mr Michael Norris serving since Jan 2013.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Michael Norris | England | 60 years | Jan 2013 | - | Director |
NORRIS BIOMEDICAL SERVICES LIMITED financials
Norris Biomedical Services Limited's latest turnover from May 2023 is estimated at £102 thousand and the company has net assets of £54.2 thousand. According to their latest financial statements, Norris Biomedical Services Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | Jan 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 212,156 | 117,348 | ||||||||
| Other Income Or Grants | 0 | 0 | ||||||||
| Cost Of Sales | 0 | 0 | ||||||||
| Gross Profit | 212,156 | 117,348 | ||||||||
| Admin Expenses | 165,426 | 137,047 | ||||||||
| Operating Profit | 46,730 | -19,699 | ||||||||
| Interest Payable | 0 | 0 | ||||||||
| Interest Receivable | 0 | 0 | ||||||||
| Pre-Tax Profit | 46,730 | -19,699 | ||||||||
| Tax | -5,406 | 0 | ||||||||
| Profit After Tax | 41,324 | -19,699 | ||||||||
| Dividends Paid | 0 | 0 | ||||||||
| Retained Profit | 41,324 | -19,699 | ||||||||
| Employee Costs | ||||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | ||||||
| EBITDA* | 46,730 | -19,699 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | Jan 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 11,474 | 56,715 | 35,427 | 21,877 | 4,840 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 11,474 | 56,715 | 35,427 | 21,877 | 4,840 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 54,246 | 54,246 | 74,029 | 108,376 | 51,759 | 73,386 | 136,172 | 108,362 | 30,835 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22,109 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 54,246 | 54,246 | 74,029 | 108,376 | 51,759 | 73,386 | 136,172 | 108,362 | 52,944 | 0 |
| total assets | 54,246 | 54,246 | 74,029 | 108,376 | 63,233 | 130,101 | 171,599 | 130,239 | 57,784 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40,360 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 8,379 | 34,708 | 108,716 | 104,629 | 149,276 | 3,948 | 14,809 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14,305 | 12,673 | 0 |
| total current liabilities | 0 | 0 | 8,379 | 34,708 | 108,716 | 104,629 | 149,276 | 58,613 | 27,482 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 0 | 8,379 | 34,708 | 108,716 | 104,629 | 149,276 | 58,613 | 27,482 | 0 |
| net assets | 54,246 | 54,246 | 65,650 | 73,668 | -45,483 | 25,472 | 22,323 | 71,626 | 30,302 | 0 |
| total shareholders funds | 54,246 | 54,246 | 65,650 | 73,668 | -45,483 | 25,472 | 22,323 | 71,626 | 30,302 | 0 |
| May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | Jan 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | 46,730 | -19,699 | ||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Tax | -5,406 | 0 | ||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | -19,783 | -34,347 | 56,617 | -21,627 | -62,786 | 27,810 | 77,527 | 30,835 | 0 |
| Creditors | 0 | -8,379 | -26,329 | -74,008 | 4,087 | -44,647 | 145,328 | -10,861 | 14,809 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | -14,305 | 1,632 | 12,673 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -45,432 | -23,052 | ||||||||
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||
| interest | 0 | 0 | ||||||||
| cash flow from financing | 0 | 50,001 | ||||||||
| cash and cash equivalents | ||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -22,109 | 22,109 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | -40,360 | 40,360 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 40,360 | -62,469 | 22,109 | 0 |
P&L
May 2023turnover
102k
+7%
operating profit
0
0%
gross margin
25.4%
+3.24%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
May 2023net assets
54.2k
0%
total assets
54.2k
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
norris biomedical services limited company details
company number
08358664
Type
Private limited with Share Capital
industry
70229 - Management consultancy activities (other than financial management)
incorporation date
January 2013
age
11
accounts
Unaudited Abridged
ultimate parent company
previous names
critical change management limited (October 2013)
incorporated
UK
address
20 finch mill avenue, appley bridge, wigan, WN6 9DF
last accounts submitted
May 2023
norris biomedical services limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to norris biomedical services limited. Currently there are 0 open charges and 1 have been satisfied in the past.
norris biomedical services limited Companies House Filings - See Documents
| date | description | view/download |
|---|
